Issue 14, 2022

An all-in-one nanomaterial derived from rGO-MoS2 for photo/chemotherapy of tuberculosis

Abstract

A combination of therapeutic modalities has recently emerged as an alternative technique for combating Mycobacterium tuberculosis. Tuberculosis infections are difficult to treat due to the development of multi-antibiotic-resistant strains. Here, we report an all-in-one photoactive nanoagent with photothermal, photodynamic, and antimycobacterial properties. It was fabricated using polyorganophosphazene–graphene–MoS2 loaded with isoniazid (IZN) and indocyanine green (ICG). The reduced graphene–MoS2 was prepared by the L-cysteine-assisted solution-phase method. Furthermore, the fabrication was continued by functionalization of poly[bis(carboxyphenoxy)phosphazene] (PCPP) with IZN. After NIR-irradiation, ICG stacked rGO-MoS2-PCPP-IZN generates heat and also produces singlet oxygen. The 2D nanostructures prevent ICG aggregation and maintain the stability of ICG. The cumulative IZN release, higher photothermal effect (180 s), and generation of singlet oxygen are attributed to the combined therapeutic modality. rGO-MoS2-PCPP-IZN-ICG causes severe destruction of E. coli and B. subtilis membranes, and also shows good cytocompatibility. It inhibits Mycobacterial colonization and cell viability as assessed by flow cytometry. There is a higher peak shift for dead cell count after exposure to NIR-irradiation for 5 min. The combined modality effect was due to the penetration of MoS2, physical cutting of the cell membrane, hyperthermia, membrane damage by IZN, and singlet oxygen generation. Finally, the all-in-one photoactive nanoagent effectively damaged the Mycobacterium tuberculosis cell membrane with 100% efficiency in a lesser time of light exposure.

Graphical abstract: An all-in-one nanomaterial derived from rGO-MoS2 for photo/chemotherapy of tuberculosis

Supplementary files

Article information

Article type
Paper
Submitted
23 Jul 2021
Accepted
03 Mar 2022
First published
03 Mar 2022

New J. Chem., 2022,46, 6433-6445

An all-in-one nanomaterial derived from rGO-MoS2 for photo/chemotherapy of tuberculosis

S. Mehnath, K. Chitra and M. Jeyaraj, New J. Chem., 2022, 46, 6433 DOI: 10.1039/D1NJ03549E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements